• Toshinobu Yamagishi, Naoki Arakawa, Sho Toyoguchi, Koshi Mizuno, Yusuke Asami, Yurika Yamanaka, Hiroki Yamamoto, and Ken Tsuboi.
• Department of Emergency and Internal Medicine, Saitama Citizens Medical Center, Saitama, Japan.
• Medicine (Baltimore). 2022 May 27; 101 (21): e29469e29469.

RationaleSince late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had rapidly spread worldwide, resulting in a pandemic. Patients with coronavirus disease 2019 (COVID-19) have difficulty in visiting clinics in person during pandemic because they might be encouraged to quarantine at home with supportive care. Peritonsillar abscess rarely coexists with COVID-19; however, patients with SARS-CoV-2 infection could get co-infections or become superinfected with other microorganisms which could cause peritonsillar abscess. We herein describe a case of peritonsillar abscess caused by Prevotella bivia that occurred as a co-infection with COVID-19 during home quarantine.Patient ConcernsA 32-year-old Asian woman who was diagnosed with COVID-19 was instructed to stay home for quarantine. Her pharyngeal discomfort worsened, and she experienced trismus and dysphagia. An emergent visiting doctor referred her to our hospital. Contrast-enhanced computed tomography showed peritonsillar abscess findings, following which we referred her to an ear, nose, throat specialist. Prevotella bivia was identified on needle aspiration pus culture; however, two sets of blood and throat cultures were negative.DiagnosisA definitive diagnosis of acute COVID-19 and peritonsillar abscess due to Prevotella bivia was made.InterventionsAn antibiotic drug, antiviral drug, and adjunctive steroid were administered intravenously.OutcomesHer symptoms improved without the need for incision and drainage, and she was discharged on day 7.ConclusionPatients with suspected peritonsillar abscess should be triaged and referred to ear, nose, throat specialists appropriately. Scoring systems, such as modified Liverpool peritonsillar abscess score or the guidelines criteria might be useful tools to triage patients. During the early phase of SARS-CoV-2 infection, administration of corticosteroids is not recommended. When adjunctive steroids are considered for peritonsillar abscess, prior to or simultaneous use of the antiviral agent remdesivir for COVID-19 might be recommended.Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

26 keywords...

hide…